Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C. A. Lewandowski"'
Publikováno v:
Experimental Heat Transfer. 16:255-271
A 2-D boundary-element model was used to solve the steady-state heat conduction problem in a wood cutting tool. Cutting experiments were conducted in order to measure temperatures at remote locations on the tool rake face and at the tool/holder inter
Autor:
E. C. Haley, C. A. Lewandowski, John R. Marler, T. G. Brott, M. Lu, J. C. Grotta, P. C. Lyden, Joseph P. Broderick, S. H. Horowitz, T. P. Kwiatkowski, B. C. Tilley, Steven R. Levine, M. P. Frankel
Publikováno v:
Neurology. 55:1649-1655
Background: The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study showed a similar percentage of intracranial hemorrhage and good outcome in patients 3 months after stroke treatment given 0 to 90 minutes and 91 to 180
Autor:
L, Derex, T A, Tomsick, T G, Brott, C A, Lewandowski, M R, Frankel, W, Clark, S, Starkman, J, Spilker, G J, Udsten, J, Khoury, J C, Grotta, J P, Broderick
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Follow-up imaging data from stroke patients without angiographically apparent arterial occlusions at symptom onset are lacking. We reviewed our Emergency Management of Stroke (EMS) trial experience to determine the clinical an
Autor:
T G, Kwiatkowski, R B, Libman, M, Frankel, B C, Tilley, L B, Morgenstern, M, Lu, J P, Broderick, C A, Lewandowski, J R, Marler, S R, Levine, T, Brott
Publikováno v:
The New England journal of medicine. 340(23)
In 1995, the two-part National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator Stroke Trial found that patients who were treated with tissue plasminogen activator (t-PA) within three hours after the ons
Autor:
C A, Lewandowski, J, Kahler
Publikováno v:
American heart journal. 137(5)
Autor:
A F, Ognjan, C A, Lewandowski, B T, Belian, J, Burczak, N, Markowitz, H, Lee, L D, Saravolatz
Publikováno v:
Henry Ford Hospital medical journal. 40(1-2)
During 1987-1988, a seroprevalence study of the human immunodeficiency virus (HIV-1) and the human T-cell lymphoma/leukemia virus (HTLV-I/II) was performed among Detroit intravenous drug users unaffiliated with substance abuse programs. Seroprevalenc